Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 1
2023 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Sumpavakup
Page 1
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Sangro B, Galle PR, Kelley RK, Charoentum C, De Toni EN, Ostapenko Y, Heo J, Cheng AL, Wilson Woods A, Gupta C, Abraham J, McCoy CL, Patel N, Negro A, Vogel A, Abou-Alfa GK. Sangro B, et al. J Clin Oncol. 2024 Aug 10;42(23):2790-2799. doi: 10.1200/JCO.23.01462. Epub 2024 May 28. J Clin Oncol. 2024. PMID: 38805668 Free PMC article. Clinical Trial.
Furan fatty acid extracted from Hevea brasiliensis latex increases muscle mass in mice.
Pelletier F, Durand E, Chaiyut J, Bronstein C, Pessemesse L, Vaysse L, Liengprayoon S, Gaillet S, Brioche T, Bertrand-Gaday C, Coudray C, Sultan A, Feillet-Coudray C, Casas F. Pelletier F, et al. Biomed Pharmacother. 2023 Oct;166:115330. doi: 10.1016/j.biopha.2023.115330. Epub 2023 Aug 16. Biomed Pharmacother. 2023. PMID: 37595430 Free article.
Preventive nutritional supplementation with furan fatty acid in a DIO mouse model increases muscle mass and reduces metabolic disorders.
Dore L, Durand E, Bonafos B, Chaiyut J, Vaysse L, Liengprayoon S, Gaillet S, Pessemesse L, Lambert K, Bertrand-Gaday C, Coudray C, Sultan A, Casas F, Feillet-Coudray C. Dore L, et al. Biomed Pharmacother. 2023 Aug;164:114945. doi: 10.1016/j.biopha.2023.114945. Epub 2023 May 30. Biomed Pharmacother. 2023. PMID: 37263166 Free article.
Furan fatty acids supplementation in obese mice reverses hepatic steatosis and protects against cartilage degradation.
Chaslin M, Maroun G, Durand E, Bonafos B, Assou S, Chaiyut J, Vaysse L, Ferrer V, Liengprayoon S, Brioche T, Pessemesse L, Macart M, Bertrand-Gaday C, Pers YM, Coudray C, Brondello JM, Casas F, Feillet-Coudray C. Chaslin M, et al. Biomed Pharmacother. 2025 Jun;187:118072. doi: 10.1016/j.biopha.2025.118072. Epub 2025 Apr 19. Biomed Pharmacother. 2025. PMID: 40253827 Free article.
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
Pal SK, Rosenberg JE, Hoffman-Censits JH, Berger R, Quinn DI, Galsky MD, Wolf J, Dittrich C, Keam B, Delord JP, Schellens JHM, Gravis G, Medioni J, Maroto P, Sriuranpong V, Charoentum C, Burris HA, Grünwald V, Petrylak D, Vaishampayan U, Gez E, De Giorgi U, Lee JL, Voortman J, Gupta S, Sharma S, Mortazavi A, Vaughn DJ, Isaacs R, Parker K, Chen X, Yu K, Porter D, Graus Porta D, Bajorin DF. Pal SK, et al. Cancer Discov. 2018 Jul;8(7):812-821. doi: 10.1158/2159-8290.CD-18-0229. Epub 2018 May 30. Cancer Discov. 2018. PMID: 29848605 Free PMC article.